Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125808203 | 12580820 | 3 | F | 20160720 | 20160721 | 20160802 | EXP | JP-JNJFOC-20160716430 | JANSSEN | GOCHO N, AOKI E, OKADA C, OMURA K, HIRASHIMA T, SUZUKI N, ET AL. NON-OCCLUSIVE MESENTERIC ISCHEMIA WITH DIABETIC KETOACIDOSIS AND LACTIC ACIDOSIS FOLLOWING THE ADMINISTRATION OF A SODIUM GLUCOSE CO-TRANSPORTER 2 INHIBITOR.. INTERNAL MEDICINE 2016;55/13:1755-1760. | 60.00 | YR | A | M | Y | 72.80000 | KG | 20160802 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125808203 | 12580820 | 1 | PS | CANAGLIFLOZIN | CANAGLIFLOZIN | 1 | Unknown | Y | N | 204042 | 300 | MG | TABLET | QD | |||||
| 125808203 | 12580820 | 2 | SS | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Unknown | DRUG STARTED AT THE AGE OF 42 | Y | 0 | 1000 | MG | UNSPECIFIED | QD | |||||
| 125808203 | 12580820 | 3 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | Unknown | 0 | 100 | UG | UNSPECIFIED | QD | |||||||
| 125808203 | 12580820 | 4 | C | LOSARTAN. | LOSARTAN | 1 | Unknown | 0 | 1000 | MG | UNSPECIFIED | ||||||||
| 125808203 | 12580820 | 5 | C | LOSARTAN. | LOSARTAN | 1 | Unknown | 0 | 40 | MG | UNSPECIFIED | ||||||||
| 125808203 | 12580820 | 6 | C | LOSARTAN. | LOSARTAN | 1 | Unknown | 0 | 100 | MG | UNSPECIFIED | QD | |||||||
| 125808203 | 12580820 | 7 | C | ROSUVASTATIN. | ROSUVASTATIN | 1 | Unknown | 0 | 40 | MG | UNSPECIFIED | QD | |||||||
| 125808203 | 12580820 | 8 | C | INSULIN ASPART | INSULIN ASPART | 1 | Subcutaneous | DOSE: 6-10 IU (BEFORE MEALS) | 0 | UNSPECIFIED | |||||||||
| 125808203 | 12580820 | 9 | C | INSULIN GLARGINE | INSULIN GLARGINE | 1 | Subcutaneous | IN THE MORNING | 0 | 24 | IU | UNSPECIFIED | QD | ||||||
| 125808203 | 12580820 | 10 | C | INSULIN | INSULIN NOS | 1 | Unknown | 0 | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125808203 | 12580820 | 1 | Type 2 diabetes mellitus |
| 125808203 | 12580820 | 2 | Type 2 diabetes mellitus |
| 125808203 | 12580820 | 3 | Type 2 diabetes mellitus |
| 125808203 | 12580820 | 4 | Type 2 diabetes mellitus |
| 125808203 | 12580820 | 5 | Type 2 diabetes mellitus |
| 125808203 | 12580820 | 6 | Type 2 diabetes mellitus |
| 125808203 | 12580820 | 7 | Type 2 diabetes mellitus |
| 125808203 | 12580820 | 8 | Type 2 diabetes mellitus |
| 125808203 | 12580820 | 9 | Type 2 diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125808203 | 12580820 | HO |
| 125808203 | 12580820 | LT |
| 125808203 | 12580820 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125808203 | 12580820 | Diabetic ketoacidosis | |
| 125808203 | 12580820 | Intestinal ischaemia | |
| 125808203 | 12580820 | Lactic acidosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |